Oramed Pharmaceuticals Inc: 1 director

A director at Oramed Pharmaceuticals Inc bought 8,809 shares at 2.216USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The na...

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Vital Signs: Actionable charts

Key Points: A number of Healthcare names are staging bullish reversals. (ex. CSTL, MDXG, STXS, PAVM, BLFS, HSKA, TMO, CRNX, and BLI) Several Technology companies are developing reversals or breaking to new highs. (ex. ARLO, TA, ENPH, AMD, XLNX, NVDA, ME, RVLV, SHOP, NET, VRNS, APPN, ASAN, SMAR, BILL, BLI, BLI, MDB, ZDGE, AZRE, and RUN.

PBSV: Steady as she goes

BCLI: KOL Event Gives Overview of the use of NurOwn® in Alzheimer’s Disease; Raising Valuation to $25/Share...

MNOV: FDA Gives OK to Initiate Clinical Trial of MN-166 to Prevent ARDS in COVID- 19 Patients...